Antiepileptogenesis by Transcranial Magnetic Stimulation
经颅磁刺激抗癫痫发生
基本信息
- 批准号:8062000
- 负责人:
- 金额:$ 17.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-04-01 至 2012-03-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAffectAnimal ModelAnimalsAnticonvulsantsAntiepileptogenicAttentionBrainCell DeathChronicChronic PhaseClinicalCollectionD GlutamateDNA FragmentationDataDoctor of MedicineDoctor of PhilosophyDown-RegulationElectric StimulationElectroencephalographyElectromagneticsEpilepsyEpileptogenesisEvaluationEventFDA approvedFOS geneFrequenciesFutureGlutamate ReceptorGoalsHippocampus (Brain)HumanIn SituIn VitroInjection of therapeutic agentInterneuronsInvestigationIsoxazolesLabelLeadLiteratureLong-Term DepressionLong-Term PotentiationMethodsModalityModelingMolecular Mechanisms of ActionMonitorN-MethylaspartateNeuronal InjuryNeuronsPainlessPathologicPatientsPeripheral Nerve StimulationPhasePhysiologic pulsePhysiologyProcessPropertyPropionic AcidsProtein DephosphorylationProtocols documentationPyramidal CellsRattusRecurrenceResearchRoleSeizuresSliceStagingStatus EpilepticusStimulusSurfaceSynapsesTestingTherapeuticTrainingTranscranial magnetic stimulationWorkbasebrain tissuecell injuryin vivokainatemagnetic fieldmossy fiberneuropsychiatrynovel therapeuticspreventprophylacticreceptorrepetitive transcranial magnetic stimulationresearch studytool
项目摘要
DESCRIPTION (provided by applicant): Status epilepticus (SE) is often the triggering event for epileptogenesis, a sequence of neuronal changes that lead to abnormal excitation and ultimately to epilepsy. Epileptogenesis is dependent in large part on lasting enhancement of excitatory synaptic strength that is similar to the long-term potentiation (LTP) seen with experimental high frequency repetitive neuronal stimulation. In this regard, we propose to investigate the anti-epileptogenic potential of transcranial magnetic stimulation (IMS), a noninvasive method for repetitive neuronal activation that is coming to attention as a new therapeutic tool in epilepsy. The attractive properties of TMS are its ability to 1) terminate seizures and to 2) produce a lasting decrease in synaptic strength. The latter effect may be similar to the long-term depression (LTD) that is LTP's inhibitory counterpart. Accordingly, our overall hypothesis is that the anticonvulsive and LTD-like effects of low frequency repetitive (rTMS) can interfere with SE-triggered epileptogenesis and prevent the expression of epilepsy. TMS is based on the principle of electromagnetic induction where intracranial stimulating currents are generated by a strong extracranial magnetic field. TMS is safe, painless and inexpensive. Its anticonvulsive capacity is demonstrated in a small number of human trials showing a reduction seizure frequency reduction in epileptic patients treated with rTMS. However, its mechanism of action is poorly understood. Therefore, this developing field would benefit from animal model research for elucidation of basic TMS physiology, and for evaluation of its therapeutic potential. We recently developed methods for simultaneous TMS and electroencephalography (EEG) in seizing rats, and identified new potent anti-convulsive effect. We now propose to use the rat kainate (KA) SE model to test the capacity of TMS to 1) stop SE and prevent the seizure-associate neuronal injury, and 2) prevent SE-triggered epileptogenesis. Further, to evaluate the TMS-related cellular and molecular mechanisms of action, we will test whether low frequency rTMS can induce LTD by extending our methods to in vitro hippocampal slice recording. To achieve these overall goals, we will extend our studies to include in vitro and ex vivo hippocampal slice recordings.
描述(由申请人提供):状态癫痫症(SE)通常是癫痫发生的触发事件,这是导致异常激发并最终导致癫痫病的一系列神经元变化。癫痫发生在很大程度上取决于持续增强的兴奋性突触强度,这与实验高频重复性神经元刺激相似。在这方面,我们建议研究经颅磁刺激(IMS)的抗癫痫发作潜力,这是一种无创的重复神经元激活的方法,它正引起人们对癫痫中一种新的治疗工具的关注。 TMS的吸引力是其能够1)终止癫痫发作的能力,而2)突触强度持续下降。后一种效应可能类似于LTP的抑制作用的长期抑郁(LTD)。因此,我们的总体假设是,低频重复(RTMS)的抗惊厥和LTD样效应会干扰SE触发的癫痫发生并防止癫痫的表达。 TMS基于电磁诱导的原理,其中颅内刺激电流由强颅外磁场产生。 TMS安全,无痛且便宜。在少数人类试验中证明了它的抗惊厥能力,表明用RTMS治疗的癫痫患者的癫痫发作频率降低。但是,其作用机理知之甚少。因此,这种发展的领域将受益于动物模型研究,以阐明基本TMS生理学,并评估其治疗潜力。我们最近开发了同时进行TMS和脑电图(EEG)的方法,并确定了新的有效的抗惊厥作用。现在,我们建议使用大鼠海藻(KA)SE模型测试TMS对1)停止SE的能力并防止癫痫发作缔合性神经元损伤,2)防止SE触发的癫痫发生。此外,为了评估与TMS相关的细胞和分子作用机制,我们将测试低频RTMS是否可以通过将我们的方法扩展到体外海马切片记录来诱导LTD。为了实现这些总体目标,我们将扩展研究以包括体外和离体海马切片记录。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Translational neuromodulation: approximating human transcranial magnetic stimulation protocols in rats.
- DOI:10.1111/j.1525-1403.2012.00482.x
- 发表时间:2012-07
- 期刊:
- 影响因子:0
- 作者:Vahabzadeh-Hagh AM;Muller PA;Gersner R;Zangen A;Rotenberg A
- 通讯作者:Rotenberg A
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alexander Rotenberg其他文献
Alexander Rotenberg的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alexander Rotenberg', 18)}}的其他基金
Developing an inducible mouse model for gene replacement therapy in Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD)
开发用于琥珀半醛脱氢酶缺乏症 (SSADHD) 基因替代疗法的诱导小鼠模型
- 批准号:
10544054 - 财政年份:2022
- 资助金额:
$ 17.33万 - 项目类别:
Developing an inducible mouse model for gene replacement therapy in Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD)
开发用于琥珀半醛脱氢酶缺乏症 (SSADHD) 基因替代疗法的诱导小鼠模型
- 批准号:
10380224 - 财政年份:2022
- 资助金额:
$ 17.33万 - 项目类别:
Astrocytic Glutamate Transporter 1 (GLT-1) enhancement for the treatment of seizures in Dravet Syndrome
星形细胞谷氨酸转运蛋白 1 (GLT-1) 增强治疗 Dravet 综合征癫痫发作
- 批准号:
10288936 - 财政年份:2021
- 资助金额:
$ 17.33万 - 项目类别:
Neurophysiologic investigation of somatosensory dysfunction in Autism Spectrum Disorders
自闭症谱系障碍体感功能障碍的神经生理学研究
- 批准号:
10057023 - 财政年份:2020
- 资助金额:
$ 17.33万 - 项目类别:
Mapping progressive loss of intracortical inhibition by TMS and EEG in posttraumatic epileptogenesis
通过 TMS 和 EEG 绘制创伤后癫痫发生过程中皮质内抑制的逐渐丧失
- 批准号:
8888294 - 财政年份:2015
- 资助金额:
$ 17.33万 - 项目类别:
Mapping progressive loss of intracortical inhibition by TMS and EEG in posttraumatic epileptogenesis
通过 TMS 和 EEG 绘制创伤后癫痫发生过程中皮质内抑制的逐渐丧失
- 批准号:
9215704 - 财政年份:2015
- 资助金额:
$ 17.33万 - 项目类别:
Antiepileptogenesis by Transcranial Magnetic Stimulation
经颅磁刺激抗癫痫发生
- 批准号:
7390304 - 财政年份:2007
- 资助金额:
$ 17.33万 - 项目类别:
Antiepileptogenesis by Transcranial Magnetic Stimulation
经颅磁刺激抗癫痫发生
- 批准号:
7613431 - 财政年份:2007
- 资助金额:
$ 17.33万 - 项目类别:
Antiepileptogenesis by Transcranial Magnetic Stimulation
经颅磁刺激抗癫痫发生
- 批准号:
7209565 - 财政年份:2007
- 资助金额:
$ 17.33万 - 项目类别:
Antiepileptogenesis by Transcranial Magnetic Stimulation
经颅磁刺激抗癫痫发生
- 批准号:
7805495 - 财政年份:2007
- 资助金额:
$ 17.33万 - 项目类别:
相似国自然基金
肾—骨应答调控骨骼VDR/RXR对糖尿病肾病动物模型FGF23分泌的影响及中药的干预作用
- 批准号:82074395
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
基于细胞自噬调控的苦参碱对多囊肾小鼠动物模型肾囊肿形成的影响和机制研究
- 批准号:
- 批准年份:2019
- 资助金额:33 万元
- 项目类别:地区科学基金项目
靶向诱导merlin/p53协同性亚细胞穿梭对听神经瘤在体生长的影响
- 批准号:81800898
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
伪狂犬病病毒激活三叉神经节细胞对其NF-кB和PI3K/Akt信号转导通路影响的分子机制研究
- 批准号:31860716
- 批准年份:2018
- 资助金额:39.0 万元
- 项目类别:地区科学基金项目
基于中枢胰岛素抵抗探讨自噬失调对肾虚阿尔茨海默的影响及机制研究
- 批准号:81803854
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
相似海外基金
The Role of Dopamine in Cognitive Resilience to Alzheimer's Disease Pathology in Healthy Older Adults
多巴胺在健康老年人阿尔茨海默氏病病理认知弹性中的作用
- 批准号:
10678125 - 财政年份:2023
- 资助金额:
$ 17.33万 - 项目类别:
Prevention of intracellular infection in diabetic wounds by commensal Staphylococcus epidermidis
共生表皮葡萄球菌预防糖尿病伤口细胞内感染
- 批准号:
10679628 - 财政年份:2023
- 资助金额:
$ 17.33万 - 项目类别:
Design and testing of a novel circumesophageal cuff for chronic bilateral subdiaphragmatic vagal nerve stimulation (sVNS)
用于慢性双侧膈下迷走神经刺激(sVNS)的新型环食管套囊的设计和测试
- 批准号:
10702126 - 财政年份:2023
- 资助金额:
$ 17.33万 - 项目类别:
The Injectrode- An injectable, easily removable electrode as a trial lead for baroreceptor activation therapy to treat hypertension and heart failure
Injectrode——一种可注射、易于拆卸的电极,作为压力感受器激活疗法的试验引线,以治疗高血压和心力衰竭
- 批准号:
10697600 - 财政年份:2023
- 资助金额:
$ 17.33万 - 项目类别: